Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination against cutaneous leishmaniasis: current status.

Peter C Melby1

  • 1Department of Veterans Affairs Medical Center, Medical Service, South Texas Veterans Health Care System, San Antonio, TX 78229, USA. melby@uthscsa.edu

American Journal of Clinical Dermatology
|October 3, 2002
PubMed
Summary

Developing effective cutaneous leishmaniasis vaccines is crucial for disease prevention. Strategies focus on whole parasite or subunit vaccines to induce durable protective immunity against Leishmania.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Rickettsia parkeri</i> as a Probable Agent of Mild Spotted-Fever Group Rickettsiosis Identified by Seroreactivity in Villeta, Colombia.

Tropical medicine and infectious disease·2026
Same author

Dietary fish oil improves intestinal barrier function and intestinal microbiota composition and reduces systemic inflammation in a mouse model of moderate acute malnutrition.

Journal of nutritional science·2026
Same author

Undernutrition-related diabetes in mice is linked to early undernutrition.

American journal of physiology. Endocrinology and metabolism·2026
Same author

Investigation of neglected bacterial pathogens provides molecular and serological evidence of Bartonella spp. in patients with acute undifferentiated febrile illness in Villeta, Colombia.

Parasites & vectors·2026
Same author

Francisella spp. as an overlooked cause of acute undifferentiated febrile illness in Colombia? Unexpected evidence from febrile patients negative for other common and neglected etiologies in Villeta municipality.

Tropical medicine and health·2026
Same author

Probable scrub typhus-like infection in Colombia: seroconversion and serological reactivity to Orientia spp. among patients with acute undifferentiated febrile illness in Villeta municipality.

Travel medicine and infectious disease·2025

Area of Science:

  • Immunology
  • Infectious Diseases
  • Parasitology

Background:

  • Cutaneous leishmaniasis presents as distinct clinical forms with varied etiology and epidemiology.
  • Natural infection typically induces protective immunity, suggesting vaccine feasibility.
  • Current vaccine research avoids live parasites due to adverse events, exploring killed, attenuated, or subunit vaccines.

Purpose of the Study:

  • To review strategies for developing effective vaccines against cutaneous leishmaniasis.
  • To highlight the importance of inducing durable, broad-based immune responses.
  • To discuss promising vaccine candidates and the mechanisms of protective immunity.

Main Methods:

  • Review of existing literature on cutaneous leishmaniasis and vaccine development.

Related Experiment Videos

  • Analysis of immune responses, including T cell populations and cytokine production (e.g., interferon-gamma).
  • Evaluation of different vaccine platforms: whole parasite, subunit, DNA vaccines, and adjuvants.

    • Main Results:

    • Whole parasite vaccines offer multiple epitopes for broad immune stimulation.
    • Persistent antigen exposure and sustained interleukin-12 expression are key for immunity.
    • DNA vaccines show promise for sustained antigen expression, mimicking subclinical infection.
    • Effective vaccines must elicit rapid, type 1 T cell responses for parasite clearance.

    Conclusions:

    • Vaccination strategies aim to induce antigen-specific memory T cells for prompt recall responses.
    • Interferon-gamma-mediated macrophage activation is critical for killing intracellular Leishmania parasites.
    • While sterile immunity is unlikely, vaccines should control parasite load and prevent severe disease.